Calcium phosphate bone cement represents the fastest-growing segment in the orthopedic bone cement market, driven by its bioactive properties, biocompatibility, and potential to promote natural bone healing. Calcium phosphate cements are gaining traction thanks to their bioactive characteristics, making them an appealing choice for enhancing bone healing and regeneration efforts [citation:MRFR]. Unlike PMMA, which is non-resorbable, calcium phosphate cements are bioresorbable and can be remodeled by the body, potentially leading to superior long-term outcomes.

Calcium phosphate bone cements are typically used in applications where bone regeneration is desired, such as in filling bone voids, treating fractures in osteoporotic bone, and augmenting screw fixation. They can be injected directly into the bone defect or fracture site, where they set in situ to form a mechanically supportive scaffold that is gradually replaced by new bone. The rise of minimally invasive surgical techniques is supporting the adoption of calcium phosphate cements, as their injectable form enables smaller incisions and precise placement. The calcium phosphate segment is also benefiting from the growing demand for bone graft substitutes and the shift towards materials that promote natural healing. By 2035, calcium phosphate bone cement is expected to experience the highest growth rate among material types, driven by the increasing adoption of bioactive materials and the focus on improved patient outcomes [citation:MRFR]. The market for these cements is projected to expand as they become more widely used in spinal surgery, trauma surgery, and other orthopedic applications, particularly as they are available in injectable and prepackaged forms [citation:MRFR].

Get More Insights: Orthopedic Bone Cement Casting Material Market Report

• algae ink market
• aminophenol market
• antibacterial glass market